| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112605 cyclooxygenase-2 (COX-2) inhibitors; Non-steroidal anti-inflammatory drugs (NSAIDs) with side effect reduction; N-propyl-3-(4-methylsulfonylphenyl)-4-(4-chlorophenyl)-2,5-dihydropyrrole-2-one for example; rheumatoid arthritis |
| 09/26/2006 | US7112604 Process for the preparation of Atorvastatin and intermediates |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/21/2006 | WO2006099352A1 Novel isophthalates as beta-secretase inhibitors |
| 09/21/2006 | WO2006098918A2 Substituted gamma lactams as therapeutic agents |
| 09/21/2006 | WO2006098444A1 Process for production of fluoro derivative |
| 09/21/2006 | WO2006097909A1 Preparation of an atorvastatin intermediate using a paal-knorr condensation |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097270A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 09/21/2006 | WO2006097197A1 Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives |
| 09/21/2006 | WO2006097175A1 Dpp-iv inhibitors |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211869 Amidating a p-(benzyloxy)aniline derivative with (S)-N-(5-oxo-tetrahydro-furan-3-yl)-acetamide and cyclizing the product to form 1-(p-(benzyloxy)phenyl)-4-acetamido-2-pyrrolidone derivatives; N-(p-(benzyloxy)phenyl-3-acetamido-4-hydroxybutyramide derivatives |
| 09/21/2006 | US20060211868 Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives |
| 09/21/2006 | US20060211761 Hmg-coa-reductase inhibitors |
| 09/21/2006 | US20060211740 Novel compounds |
| 09/21/2006 | US20060211692 reacting cis-hydroxy-D-proline with 4-chlorophenyl iso-cyanate forming intermediate 1(4-chlorophenylcarbamoyl)-4-hydroxypyrrolidine-2-carboxylic acid, reacting intermediate with aminophenylmorpholinone; 1-[(4-chlorophenyl)]-2-{[4-(3-oxomorpholin-4-yl)phenyl]}-(2R)-pyrrolidine-1,2-dicarboxamide |
| 09/21/2006 | US20060211097 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 09/21/2006 | DE102005012681A1 New 1,5-dihydro-pyrrol-2-one compounds are HDM2 inhibitors, useful for treating e.g. stroke, heart infarct, ischemia, multiple sclerosis, Alzheimer's disease, degenerative disease, viral infection and cancer |
| 09/21/2006 | CA2602173A1 Dpp-iv inhibitors |
| 09/21/2006 | CA2601416A1 Method for preparing enantiomerically pure 4-pyrrolidinophenyl benzyl ether derivatives |
| 09/21/2006 | CA2601111A1 Preparation of an atorvastatin intermediate using a paal-knorr condensation |
| 09/21/2006 | CA2600761A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599425A1 Substituted gamma lactams as therapeutic agents |
| 09/20/2006 | EP1702916A1 DPP-IV inhibitors |
| 09/20/2006 | EP1701949A2 Assay for entactogens |
| 09/20/2006 | EP1701945A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 09/20/2006 | EP1701939A1 Anthraquinone compounds as anti cancer compounds |
| 09/20/2006 | EP1341757B1 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses |
| 09/20/2006 | EP1301520B1 Ligands, complex compounds and their use for polymerising olefins |
| 09/20/2006 | CN1835921A N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 09/20/2006 | CN1834088A Tetrapeptide derivative crystals |
| 09/20/2006 | CN1276530C Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 09/20/2006 | CN1275963C Process for production of naphthyridine-3-carboxylic acid derivatives |
| 09/20/2006 | CN1275941C Process for producing aziridine compound and N-vinyl amide |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/19/2006 | US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts |
| 09/19/2006 | US7109343 Metal catalysts and methods for making and using same |
| 09/19/2006 | US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs |
| 09/19/2006 | US7109232 Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity |
| 09/19/2006 | US7109217 Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109153 Photo-labile pro-fragrance conjugates |
| 09/19/2006 | US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/19/2006 | CA2255664C Selenophene anti-tumor agents |
| 09/14/2006 | WO2006095568A1 Process for oxidation of organic compounds |
| 09/14/2006 | WO2006095362A1 Process for preparing levetiracetam |
| 09/14/2006 | WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/14/2006 | WO2006094648A1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
| 09/14/2006 | WO2006078593A3 Direct compression formulation and process |
| 09/14/2006 | WO2006056166A3 Method for the addition of amides ureas lactams and carbamates to alkynes |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205953 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 09/14/2006 | US20060205805 Crystalline polymorphic forms; storage stability, thermostability, solubility |
| 09/14/2006 | US20060205804 Process for preparing 5-(4-fluorophenyl)-1-[2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/14/2006 | US20060205788 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/14/2006 | US20060205709 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 09/14/2006 | CA2640120A1 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo(3.1.0) hexanes |
| 09/14/2006 | CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/14/2006 | CA2597120A1 Methods for oxidizing organic compounds |
| 09/13/2006 | EP1700848A1 Method for the Manufacture of Compounds Related to the Class of Substituted Sulphonyl Urea Anti-Diabetics |
| 09/13/2006 | EP1700116A1 Trityl derivatives for enhancing mass spectrometry |
| 09/13/2006 | EP1700109A2 Acousto-mechanical detection systems and methods of use |
| 09/13/2006 | EP1699900A2 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 09/13/2006 | EP1699790A2 Soluble polymers as amine capture agents and methods |
| 09/13/2006 | EP1699768A2 Multifunctional amine capture agents |
| 09/13/2006 | EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/13/2006 | EP1345604B1 Use of a alpha-halogen-acryloyl distamycin derivate for the preparation of a medicament for the treatment of cancer |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832920A Aryl and heteroaryl compounds, compositions, and methods of use |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105646 Mono- and bis-hydrazone pigments |
| 09/12/2006 | US7105565 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/08/2006 | WO2006094248A1 Aryl-substituted cyclic sirtuin modulators |
| 09/08/2006 | WO2006093352A1 Compound having cyclic structure and use thereof |
| 09/08/2006 | WO2006092822A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chloro phenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpi pεrazine, synthesis process and uses thereof |
| 09/08/2006 | WO2006092617A1 Crystallisation and purification of glycopyrronium bromide |
| 09/08/2006 | WO2006092037A1 Process for producing atorvastatin hemicalcium |
| 09/08/2006 | WO2006008091A3 Oxidative degradation products of atorvastatin calcium |
| 09/08/2006 | WO2006004433A3 Substituted pyrrolidine compounds, compositions and methods for controlling plant pests |
| 09/08/2006 | CA2601129A1 Crystallisation and purification of glycopyrronium bromide |
| 09/08/2006 | CA2599352A1 Novel lipoxygenase inhibitors |